期刊文献+

对胃癌、结直肠癌转移患者的临床应对措施 被引量:3

下载PDF
导出
摘要 目的探讨胃癌、结直肠癌转移的患者在临床表现及其病理特点,制定疾病的诊疗方案,对病情的预后做出评估。方法选取该院2008年5月—2012年5月住院期间诊断为胃癌、结直肠癌的50例患者的临床资料进行回顾性研究分析。将其病理特点、癌转移情况和原发部位做好记录,对此做出患者的诊疗措施,对预后进行分析。结果 50例患者中有30例患者胃癌结直肠癌肝转移,20例发生胃癌和结直肠癌盆腔种植。盆腔种植的患者无特殊临床症状,多为术中发现,并且预后不良。胃癌、结直肠癌肝转移的患者进行何种手术方式治疗及其癌症分期对患者的预后有着重大的影响。结论胃癌、结直肠癌患者发生盆腔种植的预后情况,与原发病灶的病理学特征以及肿瘤的类型、治疗方案的选择对其预后都有重要影响。由于肝癌的转移分期直接影响着患者的预后,所以应早期发现癌症转移的患者。应尽早的进行手术,切除原发病灶和转移病灶,使用化疗对改善患者的预后有一定的效果。
作者 易飞
出处 《中外医疗》 2013年第9期39-40,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献7

二级参考文献101

  • 1Xiong-Zhi Wu, Feng Ma, Xue-Lin Wang.Serological diagnostic factors for liver metastasis in patients with colorectal cancer[J].World Journal of Gastroenterology,2010,16(32):4084-4088. 被引量:17
  • 2安大立,李志霞,吴江平,韩加刚.结直肠癌临床病理特征与复发和转移的相关性研究[J].中华胃肠外科杂志,2004,7(6):450-452. 被引量:6
  • 3秦新裕,许剑民,刘凤林,钟芸诗.进展期消化道肿瘤术前介入治疗的评价[J].中国实用外科杂志,2005,25(5):307-309. 被引量:13
  • 4Tanaka T, Kumagal K, Shimizu K, et al. Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement ; extranodal invasion is a significant risk factor for peritoneal metastasis. J Surg Oncol,2000,75:165-171.
  • 5Kakushima N, Kamoshida T, Hirai S, et al. Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor. J Gastroenterol, 2003, 38: 1176-1180.
  • 6Benaaboud I, Ghazli M, Kerroumi M, et al. Krukenberg tumor: 9 cases report. J Gynecol Obstet Biol Reprod (Paris) ,2002,31 : 365 -370.
  • 7Yoshikawa T, Kanari M, Tsuburaya A, et al. Should gastric with peritoneal metastasis be treated surgically? Hepatogastroenterology, 2003,50 : 1712-1715.
  • 8Glehen O, Mithieux F, Osinaky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase Ⅱ study. J Clin Oncol, 2003, 21 : 799-806.
  • 9Samel S, Singal A, Becker H, et al. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer. Eur J Surg Oncol, 2000, 26: 222-226.
  • 10Sugarbaker PH. Peritonectomy procedures. Ann Surgery, 1995, 221 : 29-42.

共引文献37

同被引文献26

  • 1Francisco Igor B Macedo,Tafadzwa Makarawo.Colorectal hepatic metastasis: Evolving therapies[J].World Journal of Hepatology,2014,6(7):453-463. 被引量:9
  • 2Hirsch HA,Iliopoulos,Struhl K.Metformin inhibits the inflammatory re- sponse associated with cellular transformation and cancer stem cell growth[J]. Proceedings of the National Academy of Sciences of the Unit- ed States of America,2013,110(3):972-977.
  • 3Chen SW,Tsan YT,Chen JD,et al.Use of thiazolidined iones and the risk of colorectal cancer in patients with diabetes: A nationwide, population- based, case-control study[J].Diabetes care,2013,36(2):369-375.
  • 4Rendell M,Akturk HK,Tella SH.Glargine safety, diabetes and cancer[J]. Expert opinion on drug safety,2013,12(2):247-263.
  • 5Cavicchia PP,Adams SA,Steck SE,et al.Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status[J]. Cancer causes and control,2013,24(2):277-285.
  • 6Aggarwal G, Kamada P,Chari ST.Prevalence of diabetes meUitus in pan- creatic cancer compared to common cancers[J].Pancreas,2013,42(2): 198- 201.
  • 7Wang JY,Chao Tr, Lai CC,et al.Risk of colorectal cancer in type 2 dia- betic patients: A population-based cohort study[J]. Japanese Journal of Clinical OncoIogy,2013,43(3):258-263.
  • 8何忠杰,江荣科,朱丹丹,刘磊.奥沙利铂联合替吉奥胶囊治疗晚期胃癌的临床观察[J].实用癌症杂志,2010,25(3):286-288. 被引量:74
  • 9何苗,程宏文.替吉奥联合奥沙利铂治疗晚期结直肠癌的疗效观察[J].实用临床医药杂志,2011,15(17):110-112. 被引量:16
  • 10仲英洁,胡云.胰岛素抵抗和胰岛素受体亚型A与肿瘤[J].医学综述,2012,18(3):339-341. 被引量:6

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部